X4 Pharmaceuticals, Inc.XFORNASDAQ
Loading
Year-over-year earnings per share growth rate
3Y CAGR
+2.4%/yr
Annual compound
5Y CAGR
+14.9%/yr
Recent deceleration
Percentile
P80
Within normal range
vs 5Y Ago
2x
Strong expansion
Streak
1 yr
Consecutive declineStable
| Period | Value |
|---|---|
| 2025 | 66.55% |
| 2024 | 67.31% |
| 2023 | 62.50% |
| 2022 | 61.90% |
| 2021 | -29.13% |
| 2020 | 33.26% |
| 2019 | 94.15% |
| 2018 | -44.95% |
| 2017 | 5.79% |
| 2016 | -73.75% |